# FDA Inspection 1076644 - APL HEALTHCARE LIMITED - October 26, 2018

Source: https://www.keypedia.com/records/fda_inspections/apl-healthcare-limited/7c9d895b-88f0-4f35-bd67-0fff0020b036
Source feed: FDA_Inspections

> FDA Inspection 1076644 for APL HEALTHCARE LIMITED on October 26, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1076644
- Company Name: APL HEALTHCARE LIMITED
- Inspection Date: 2018-10-26
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1295002 - 2025-12-17](https://www.keypedia.com/records/fda_inspections/apl-healthcare-limited/b9a43465-8737-4efd-b442-211a1123069f)
- [FDA Inspection 1121028 - 2020-02-28](https://www.keypedia.com/records/fda_inspections/apl-healthcare-limited/d6a2534e-5658-4756-9fde-a62524b8c09c)
- [FDA Inspection 1090528 - 2019-04-19](https://www.keypedia.com/records/fda_inspections/apl-healthcare-limited/6c33f24c-a33e-4953-801e-79ed55528f90)
- [FDA Inspection 1089710 - 2019-03-20](https://www.keypedia.com/records/fda_inspections/apl-healthcare-limited/825b91cc-6479-4654-8623-4d7104ed3484)

Company: https://www.keypedia.com/companies/apl-healthcare-limited/d13ff022-135e-4790-b958-7f0667d985ab

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c